@ASCO presented by @MyMKaiser ➡️ Dara-CVRD for Ultra High Risk #myeloma and Plasmacell leukemia induces deep remissions ➡️but still with shorter PFS #ASCO21 #mmsm pic.twitter.com/mkkFPNwpdi
— Suzanne Lentzsch, MD, PhD (@SLentzsch) June 8, 2021
by MM360 Staff | Jun 10, 2021 | Twitter | 0 comments
@ASCO presented by @MyMKaiser ➡️ Dara-CVRD for Ultra High Risk #myeloma and Plasmacell leukemia induces deep remissions ➡️but still with shorter PFS #ASCO21 #mmsm pic.twitter.com/mkkFPNwpdi
— Suzanne Lentzsch, MD, PhD (@SLentzsch) June 8, 2021